Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

LJ-2698, an Adenosine A3 Receptor Antagonist, Alleviates Elastase-Induced Pulmonary Emphysema in Mice

  • Boo, Hye-Jin (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Park, So Jung (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Noh, Myungkyung (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Min, Hye-Young (Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University) ;
  • Jeong, Lak Shin (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) ;
  • Lee, Ho-Young (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
  • Received : 2019.09.30
  • Accepted : 2019.12.24
  • Published : 2020.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Emphysema, a major component of chronic obstructive pulmonary disease (COPD), is a leading cause of human death worldwide. The progressive deterioration of lung function that occurs in the disease is caused by chronic inflammation of the airway and destruction of the lung parenchyma. Despite the main impact of inflammation on the pathogenesis of emphysema, current therapeutic regimens mainly offer symptomatic relief and preservation of lung function with little therapeutic impact. In the present study, we aimed to discover novel therapeutics that suppress the pathogenesis of emphysema. Here, we show that LJ-2698, a novel and highly selective antagonist of the adenosine A3 receptor, a G protein-coupled receptor involved in various inflammatory diseases, significantly reversed the elastase-induced destructive changes in murine lungs. We found that LJ-2698 significantly prevented elastase-induced airspace enlargement, resulting in restoration of pulmonary function without causing any obvious changes in body weight in mice. LJ-2698 was found to inhibit matrix metalloproteinase activity and pulmonary cell apoptosis in the murine lung. LJ-2698 treatment induced increases in anti-inflammatory cytokines in macrophages at doses that displayed no significant cytotoxicity in normal cell lines derived from various organs. Treatment with LJ-2698 significantly increased the number of anti-inflammatory M2 macrophages in the lungs. These results implicate the adenosine A3 receptor in the pathogenesis of emphysema. Our findings also demonstrate the potential of LJ-2698 as a novel therapeutic/preventive agent in suppressing disease development with limited toxicity.

Keywords

References

  1. Abdulkhaleq, L. A., Assi, M. A., Abdullah, R., Zamri-Saad, M., Taufiq-Yap, Y. H. and Hezmee, M. N. M. (2018) The crucial roles of inflammatory mediators in inflammation: a review. Vet. World 11, 627-635. https://doi.org/10.14202/vetworld.2018.627-635
  2. Barnes, P. J., Burney, P. G., Silverman, E. K., Celli, B. R., Vestbo, J., Wedzicha, J. A. and Wouters, E. F. (2015) Chronic obstructive pulmonary disease. Nat. Rev. Dis. Primers 1, 15076. https://doi.org/10.1038/nrdp.2015.76
  3. Borea, P. A., Varani, K., Vincenzi, F., Baraldi, P. G., Tabrizi, M. A., Merighi, S. and Gessi, S. (2015) The A3 adenosine receptor: history and perspectives. Pharmacol. Rev. 67, 74-102. https://doi.org/10.1124/pr.113.008540
  4. Bouhlel, M. A., Derudas, B., Rigamonti, E., Dievart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., Staels, B. and Chinetti-Gbaguidi, G. (2007) PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137-143. https://doi.org/10.1016/j.cmet.2007.06.010
  5. Cazzola, M., Page, C. P., Calzetta, L. and Matera, M. G. (2012) Emerging anti-inflammatory strategies for COPD. Eur. Respir. J. 40, 724-741. https://doi.org/10.1183/09031936.00213711
  6. Celli, B. R. (2018) Pharmacological therapy of COPD: reasons for optimism. Chest 154, 1404-1415. https://doi.org/10.1016/j.chest.2018.07.005
  7. Chen, Z. H., Lam, H. C., Jin, Y., Kim, H. P., Cao, J., Lee, S. J., Ifedigbo, E., Parameswaran, H., Ryter, S. W. and Choi, A. M. K. (2010) Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc. Natl. Acad. Sci. U.S.A. 107, 18880-18885. https://doi.org/10.1073/pnas.1005574107
  8. Dorotea, D., Cho, A., Lee, G., Kwon, G., Lee, J., Sahu, P. K., Jeong, L. S., Cha, D. R. and Ha, H. (2018) Orally active, species-independent novel A3 adenosine receptor antagonist protects against kidney injury in db/db mice. Exp. Mol. Med. 50, 38.
  9. Duc Dodon, M. and Vogel, S. N. (1985) Analysis of effects of lipopolysaccharide and interferon on murine macrophages: modulation of elastase secretion in vitro. Infect. Immun. 49, 709-714. https://doi.org/10.1128/iai.49.3.709-714.1985
  10. Dunnill, M. S. (1962) Quantitative methods in the study of pulmonary pathology. Thorax 17, 320-328. https://doi.org/10.1136/thx.17.4.320
  11. Ferry, G., Lonchampt, M., Pennel, L., de Nanteuil, G., Canet, E. and Tucker, G. C. (1997) Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett. 402, 111-115. https://doi.org/10.1016/S0014-5793(96)01508-6
  12. Ginzberg, H. H., Shannon, P. T., Suzuki, T., Hong, O., Vachon, E., Moraes, T., Abreu, M. T., Cherepanov, V., Wang, X., Chow, C. W. and Downey, G. P. (2004) Leukocyte elastase induces epithelial apoptosis: role of mitochondial permeability changes and Akt. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G286-G298. https://doi.org/10.1152/ajpgi.00350.2003
  13. Gooptu, B., Ekeowa, U. I. and Lomas, D. A. (2009) Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights. Eur. Respir. J. 34, 475-488. https://doi.org/10.1183/09031936.00096508
  14. Guarascio, A. J., Ray, S. M., Finch, C. K. and Self, T. H. (2013) The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon. Outcomes Res. 5, 235-245. https://doi.org/10.2147/CEOR.S34321
  15. Henke, M. O., John, G., Rheineck, C., Chillappagari, S., Naehrlich, L. and Rubin, B. K. (2011) Serine proteases degrade airway mucins in cystic fibrosis. Infect. Immun. 79, 3438-3444. https://doi.org/10.1128/IAI.01252-10
  16. Horio, Y., Ichiyasu, H., Kojima, K., Saita, N., Migiyama, Y., Iriki, T., Fujii, K., Niki, T., Hirashima, M. and Kohrogi, H. (2017) Protective effect of Galectin-9 in murine model of lung emphysema: involvement of neutrophil migration and MMP-9 production. PLoS ONE 12, e0180742. https://doi.org/10.1371/journal.pone.0180742
  17. Hou, H. H., Cheng, S. L., Chung, K. P., Wei, S. C., Tsao, P. N., Lu, H. H., Wang, H. C. and Yu, C. J. (2014) PlGF mediates neutrophil elastase-induced airway epithelial cell apoptosis and emphysema. Respir. Res. 15, 106. https://doi.org/10.1186/s12931-014-0106-1
  18. Hou, H. H., Cheng, S. L., Liu, H. T., Yang, F. Z., Wang, H. C. and Yu, C. J. (2013) Elastase induced lung epithelial cell apoptosis and emphysema through placenta growth factor. Cell Death Dis. 4, e793. https://doi.org/10.1038/cddis.2013.329
  19. Jeong, L. S., Choe, S. A., Gunaga, P., Kim, H. O., Lee, H. W., Lee, S. K., Tosh, D. K., Patel, A., Palaniappan, K. K., Gao, Z. G., Jacobson, K. A. and Moon, H. R. (2007) Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists. J. Med. Chem. 50, 3159-3162. https://doi.org/10.1021/jm070259t
  20. Kapadia, R., Yi, J. H. and Vemuganti, R. (2008) Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front. Biosci. 13, 1813-1826. https://doi.org/10.2741/2802
  21. Krzyszczyk, P., Schloss, R., Palmer, A. and Berthiaume, F. (2018) The Role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes. Front. Physiol. 9, 419. https://doi.org/10.3389/fphys.2018.00419
  22. Lee, S. H., Goswami, S., Grudo, A., Song, L. Z., Bandi, V., Goodnight-White, S., Green, L., Hacken-Bitar, J., Huh, J., Bakaeen, F., Coxson, H. O., Cogswell, S., Storness-Bliss, C., Corry, D. B. and Kheradmand, F. (2007) Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat. Med. 13, 567-569. https://doi.org/10.1038/nm1583
  23. Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408. https://doi.org/10.1006/meth.2001.1262
  24. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., Alvarado, M., Anderson, H. R., Anderson, L. M., Andrews, K. G., Atkinson, C., Baddour, L. M., Barker-Collo, S., Bartels, D. H., Bell, M. L., Benjamin, E. J., Bennett, D., Bhalla, K., Bikbov, B., Bin Abdulhak, A., Birbeck, G., Blyth, F., Bolliger, I., Boufous, S., Bucello, C., Burch, M., Burney, P., Carapetis, J., Chen, H., Chou, D., Chugh, S. S., Coffeng, L. E., Colan, S. D., Colquhoun, S., Colson, K. E., Condon, J., Connor, M. D., Cooper, L. T., Corriere, M., Cortinovis, M., de Vaccaro, K. C., Couser, W., Cowie, B. C., Criqui, M. H., Cross, M., Dabhadkar, K. C., Dahodwala, N., De Leo, D., Degenhardt, L., Delossantos, A., Denenberg, J., Des Jarlais, D. C., Dharmaratne, S. D., Dorsey, E. R., Driscoll, T., Duber, H., Ebel, B., Erwin, P. J., Espindola, P., Ezzati, M., Feigin, V., Flaxman, A. D., Forouzanfar, M. H., Fowkes, F. G., Franklin, R., Fransen, M., Freeman, M. K., Gabriel, S. E., Gakidou, E., Gaspari, F., Gillum, R. F., Gonzalez-Medina, D., Halasa, Y. A., Haring, D., Harrison, J. E., Havmoeller, R., Hay, R. J., Hoen, B., Hotez, P. J., Hoy, D., Jacobsen, K. H., James, S. L., Jasrasaria, R., Jayaraman, S., Johns, N., Karthikeyan, G., Kassebaum, N., Keren, A., Khoo, J. P., Knowlton, L. M., Kobusingye, O., Koranteng, A., Krishnamurthi, R., Lipnick, M., Lipshultz, S. E., Ohno, S. L., Mabweijano, J., MacIntyre, M. F., Mallinger, L., March, L., Marks, G. B., Marks, R., Matsumori, A., Matzopoulos, R., Mayosi, B. M., McAnulty, J. H., McDermott, M. M., McGrath, J., Mensah, G. A., Merriman, T. R., Michaud, C., Miller, M., Miller, T. R., Mock, C., Mocumbi, A. O., Mokdad, A. A., Moran, A., Mulholland, K., Nair, M. N., Naldi, L., Narayan, K. M., Nasseri, K., Norman, P., O'Donnell, M., Omer, S. B., Ortblad, K., Osborne, R., Ozgediz, D., Pahari, B., Pandian, J. D., Rivero, A. P., Padilla, R. P., Perez-Ruiz, F., Perico, N., Phillips, D., Pierce, K., Pope, C. A., 3rd, Porrini, E., Pourmalek, F., Raju, M., Ranganathan, D., Rehm, J. T., Rein, D. B., Remuzzi, G., Rivara, F. P., Roberts, T., De Leon, F. R., Rosenfeld, L. C., Rushton, L., Sacco, R. L., Salomon, J. A., Sampson, U., Sanman, E., Schwebel, D. C., Segui-Gomez, M., Shepard, D. S., Singh, D., Singleton, J., Sliwa, K., Smith, E., Steer, A., Taylor, J. A., Thomas, B., Tleyjeh, I. M., Towbin, J. A., Truelsen, T., Undurraga, E. A., Venketasubramanian, N., Vijayakumar, L., Vos, T., Wagner, G. R., Wang, M., Wang, W., Watt, K., Weinstock, M. A., Weintraub, R., Wilkinson, J. D., Woolf, A. D., Wulf, S., Yeh, P. H., Yip, P., Zabetian, A., Zheng, Z. J., Lopez, A. D., Murray, C. J., AlMazroa, M. A. and Memish, Z. A. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128. https://doi.org/10.1016/S0140-6736(12)61728-0
  25. Mahadeva, R. and Shapiro, S. D. (2002) Chronic obstructive pulmonary disease . 3: experimental animal models of pulmonary emphysema. Thorax 57, 908-914. https://doi.org/10.1136/thorax.57.10.908
  26. Meng, F. and Lowell, C. A. (1997) Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J. Exp. Med. 185, 1661-1670. https://doi.org/10.1084/jem.185.9.1661
  27. Min, H. S., Cha, J. J., Kim, K., Kim, J. E., Ghee, J. Y., Kim, H., Lee, J. E., Han, J. Y., Jeong, L. S., Cha, D. R. and Kang, Y. S. (2016) Renoprotective effects of a highly selective A3 adenosine receptor antagonist in a mouse model of adriamycin-induced nephropathy. J. Korean Med. Sci. 31, 1403-1412. https://doi.org/10.3346/jkms.2016.31.9.1403
  28. Morschl, E., Molina, J. G., Volmer, J. B., Mohsenin, A., Pero, R. S., Hong, J. S., Kheradmand, F., Lee, J. J. and Blackburn, M. R. (2008) A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis. Am. J. Respir. Cell Mol. Biol. 39, 697-705. https://doi.org/10.1165/rcmb.2007-0419OC
  29. Muley, M. M., Reid, A. R., Botz, B., Bolcskei, K., Helyes, Z. and Mc-Dougall, J. J. (2016) Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2. Br. J. Pharmacol. 173, 766-777. https://doi.org/10.1111/bph.13237
  30. Mulloy, D. P., Sharma, A. K., Fernandez, L. G., Zhao, Y., Lau, C. L., Kron, I. L. and Laubach, V. E. (2013) Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury. Ann. Thorac. Surg. 95, 1762-1767. https://doi.org/10.1016/j.athoracsur.2013.01.059
  31. Papandrinopoulou, D., Tzouda, V. and Tsoukalas, G. (2012) Lung compliance and chronic obstructive pulmonary disease. Pulm. Med. 2012, 542769. https://doi.org/10.1155/2012/542769
  32. Polosa, R. and Blackburn, M. R. (2009) Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol. Sci. 30, 528-535. https://doi.org/10.1016/j.tips.2009.07.005
  33. Rothmeier, A. S. and Ruf, W. (2012) Protease-activated receptor 2 signaling in inflammation. Semin. Immunopathol. 34, 133-149. https://doi.org/10.1007/s00281-011-0289-1
  34. Sahoo, M., Del Barrio, L., Miller, M. A. and Re, F. (2014) Neutrophil elastase causes tissue damage that decreases host tolerance to lung infection with burkholderia species. PLoS Pathog. 10, e1004327. https://doi.org/10.1371/journal.ppat.1004327
  35. Sharafkhaneh, A., Hanania, N. A. and Kim, V. (2008) Pathogenesis of emphysema: from the bench to the bedside. Proc. Am. Thorac. Soc. 5, 475-477. https://doi.org/10.1513/pats.200708-126ET
  36. Suzuki, T., Moraes, T. J., Vachon, E., Ginzberg, H. H., Huang, T. T., Matthay, M. A., Hollenberg, M. D., Marshall, J., McCulloch, C. A., Abreu, M. T., Chow, C. W. and Downey, G. P. (2005) Proteinaseactivated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 33, 231-247. https://doi.org/10.1165/rcmb.2005-0109OC
  37. Tachkov, K., Kamusheva, M., Pencheva, V. and Mitov, K. (2017) Evaluation of the economic and social burden of chronic obstructive pulmonary disease (COPD). Biotechnol. Biotechnol. Equip. 31, 855-861.
  38. Tilley, S. L., Tsai, M., Williams, C. M., Wang, Z.-S., Erikson, C. J., Galli, S. J. and Koller, B. H. (2003) Identification of A3 receptor- and mast cell-dependent and -independent components of adenosine-mediated airway responsiveness in mice. J. Immunol. 171, 331-337. https://doi.org/10.4049/jimmunol.171.1.331
  39. Van Tho, N., Ogawa, E., Trang le, T. H., Ryujin, Y., Kanda, R., Nakagawa, H., Goto, K., Fukunaga, K., Higami, Y., Seto, R., Wada, H., Yamaguchi, M., Nagao, T., Lan le, T. T. and Nakano, Y. (2015) A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease. Ann. Am. Thorac. Soc. 12, 988-996. https://doi.org/10.1513/AnnalsATS.201411-501OC
  40. Vanoirbeek, J. A., Rinaldi, M., De Vooght, V., Haenen, S., Bobic, S., Gayan-Ramirez, G., Hoet, P. H., Verbeken, E., Decramer, M., Nemery, B. and Janssens, W. (2010) Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am. J. Respir. Cell Mol. Biol. 42, 96-104. https://doi.org/10.1165/rcmb.2008-0487OC
  41. Varani, K., Caramori, G., Vincenzi, F., Adcock, I., Casolari, P., Leung, E., Maclennan, S., Gessi, S., Morello, S., Barnes, P. J., Ito, K., Chung, K. F., Cavallesco, G., Azzena, G., Papi, A. and Borea, P. A. (2006) Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173, 398-406. https://doi.org/10.1164/rccm.200506-869OC
  42. von Bredow, C., Wiesener, A. and Griese, M. (2003) Proteolysis of surfactant protein D by cystic fibrosis relevant proteases. Lung 181, 79-88. https://doi.org/10.1007/s00408-003-1008-z
  43. Wedzicha, J. A., Calverley, P. M. and Rabe, K. F. (2016) Roflumilast: a review of its use in the treatment of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 81-90.
  44. Werb, Z. and Gordon, S. (1975) Elastase secretion by stimulated macrophages. Characterization and regulation. J. Exp. Med. 142, 361-377. https://doi.org/10.1084/jem.142.2.361
  45. Yang, Z. and Ming, X. F. (2014) Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders. Front. Immunol. 5, 533.
  46. Yao, H., de Boer, W. I. and Rahman, I. (2008) Targeting lung inflammation: novel therapies for the treatment of COPD. Curr. Respir. Med. Rev. 4, 57-68. https://doi.org/10.2174/157339808783497873
  47. Yu, J., Ahn, S., Kim, H. J., Lee, M., Ahn, S., Kim, J., Jin, S. H., Lee, E., Kim, G., Cheong, J. H., Jacobson, K. A., Jeong, L. S. and Noh, M. (2017) Polypharmacology of N6-(3-iodobenzyl)adenosine-5'-Nmethyluronamide (IB-MECA) and related A3 adenosine receptor ligands: peroxisome proliferator activated receptor (PPAR) $\gamma$ partial agonist and $PPAR{\delta}$ antagonist activity suggests their antidiabetic potential. J. Med. Chem. 60, 7459-7475. https://doi.org/10.1021/acs.jmedchem.7b00805
  48. Zhang, C., Yu, X., Gao, L., Zhao, Y., Lai, J., Lu, D., Bao, R., Jia, B., Zhong, L., Wang, F. and Liu, Z. (2017) Noninvasive imaging of CD206-positive M2 macrophages as an early biomarker for postchemotherapy tumor relapse and lymph node metastasis. Theranostics 7, 4276-4288. https://doi.org/10.7150/thno.20999
  49. Zhou, Y., Schneider, D. J. and Blackburn, M. R. (2009) Adenosine signaling and the regulation of chronic lung disease. Pharmacol. Ther. 123, 105-116. https://doi.org/10.1016/j.pharmthera.2009.04.003

Cited by

  1. Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer vol.10, pp.13, 2021, https://doi.org/10.3390/jcm10132889
  2. Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease vol.14, pp.10, 2020, https://doi.org/10.3390/ph14100979